Extrahepatic Anomalies in Infants With Biliary Atresia: Results of a Large Prospective North American Multicenter Study
Authors:
- Kathleen B. SchwarzKSKathleen B. Schwarz
- Philip RosenthalPRPhilip Rosenthal
- Cara L. MackCMCara L. Mack
- Jeffrey MooreJMJeffrey Moore
- Kevin BoveKBKevin Bove
- Jorge A. BezerraJBJorge A. Bezerra
- Saul J. KarpenSKSaul J. Karpen
- Nanda KerkarNKNanda Kerkar
- Benjamin L. ShneiderBSBenjamin L. Shneider
- Yumirle P. TurmelleYTYumirle P. Turmelle
- Peter F. WhitingtonPWPeter F. Whitington
Open Access
- 23 May 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 58 (5) , 1724-1731
Abstract
The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enrolled in the prospective database prior to surgery at any of 15 participating centers were evaluated. Group 1 was nonsyndromic, isolated BA (without major malformations) (n = 242, 84%), Group 2 was BA and at least one malformation considered major as defined by the National Birth Defects Prevention Study but without laterality defects (n = 17, 6%). Group 3 was syndromic, with laterality defects (n = 30, 10%). In the population as a whole, anomalies (either major or minor) were most prevalent in the cardiovascular (16%) and gastrointestinal (14%) systems. Group 3 patients accounted for the majority of subjects with cardiac, gastrointestinal, and splenic anomalies. Group 2 subjects also frequently displayed cardiovascular (71%) and gastrointestinal (24%) anomalies; interestingly, this group had genitourinary anomalies more frequently (47%) compared to Group 3 subjects (10%). Conclusion: This study identified a group of BA (Group 2) that differed from the classical syndromic and nonsyndromic groups and that was defined by multiple malformations without laterality defects. Careful phenotyping of the patterns of anomalies may be critical to the interpretation of both genetic and environmental risk factors associated with BA, allowing new insight into pathogenesis and/or outcome. (Hepatology 2013;58:1724–1731)Keywords
Funding Information
- The National Institute of Diabetes, Digestive and Kidney Diseases (U54DK078377, DK 62530 (Baltimore), DK 62436 (Chicago), DK 62497 (Cincinnati), DK 62453 (Denver), DK 62445 (Mt Sinai), DK 62481 (Philadelphia), DK 62466 (Pittsburgh), DK 62500 (San Francisco), DK 62452 (St. Louis), DK 84536 (Indiana), DK 84575 (Seattle), DK 62470 (Houston), DK 84538 (Los Angeles), DK 84585 (Atlanta), DK 62456 (Michigan))
- National Center for Research Resources (NIH (5M01 RR00069 (Denver), UL1RR025780 (Denver), UL1RR024153 (Pittsburgh), UL1RR024134 (Philadelphia), UL1RR024131 (San Francisco), UL1RR025005 (Baltimore), UL1RR025741 (Chicago))
This publication has 27 references indexed in Scilit:
- Biliary atresia with associated structural malformations in Canadian infantsLiver International, 2011
- Heterotaxy SyndromeKorean Circulation Journal, 2011
- DNA Hypomethylation Causes Bile Duct Defects in Zebrafish and Is a Distinguishing Feature of Infantile Biliary Atresia §ΔHepatology, 2010
- Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006Birth Defects Research Part A: Clinical and Molecular Teratology, 2010
- Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2Human Molecular Genetics, 2010
- Genomic alterations in biliary atresia suggest region of potential disease susceptibility in 2q37.3American Journal of Medical Genetics Part A, 2010
- The Pathogenesis of Biliary Atresia: Evidence for a Virus-Induced Autoimmune DiseaseSeminars in Liver Disease, 2007
- Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresiaHepatology, 2006
- The biliary atresia splenic malformation syndrome: A 28-year single-center retrospective studyThe Journal of Pediatrics, 2006
- Defining criteria for autoimmune diseases (Witebsky's postulates revisited)Immunology Today, 1993